Literature DB >> 3081504

Cholinergic stimulation of arachidonic acid and phosphatidic acid metabolism in C62B glioma cells.

J J DeGeorge, P Morell, K D McCarthy, E G Lapetina.   

Abstract

Glioma C62B cells were incubated for 18 h with [1-14C]arachidonic acid. Most (80%) of the added [1-14C] arachidonic acid was taken into the intracellular pool; less than 1% of the intracellular [1-14C]arachidonic acid remained unesterified; the rest was present in glycerophospholipids. Acetylcholine stimulation of the prelabeled cells resulted in the rapid accumulation of free [1-14C]arachidonic acid, presumably liberated by hydrolysis from phospholipids. Labeled unesterified [1-14C]arachidonic acid peaked by 90 s and returned to basal levels by 5 min. Paralleling the transient increase of unesterified [1-14C]arachidonic acid were increases in level of radioactivity in an unidentified lipoxygenase metabolite of arachidonic acid and of radioactive phosphatidic acid. The release of arachidonic acid induced by acetylcholine or carbachol was blocked by muscarinic but not nicotinic receptor antagonists; adrenergic or histaminergic receptor agonists were ineffective at stimulating arachidonic acid liberation. In contrast to the transient effects of stimulation with cholinergic agonists, stimulation with the divalent cation ionophore A23187 resulted in a linear increase in the accumulation of liberated arachidonic acid for at least 1 h. Furthermore, the pattern of metabolites synthesized from arachidonic acid in response to ionophore stimulation was more complex than that observed following cholinergic stimulation and included also several metabolites derived from cyclooxygenase activity. We conclude that muscarinic receptor agonists rapidly induce specific changes in arachidonic acid and phosphatidic acid metabolism in a glioma cell line and suggest that similar responses may occur in glial cells and play a physiologically significant role in neural metabolism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081504

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Stimulation of arachidonic acid release and inhibition of mitogenesis by cloned genes for muscarinic receptor subtypes stably expressed in A9 L cells.

Authors:  B R Conklin; M R Brann; N J Buckley; A L Ma; T I Bonner; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

2.  Differences in rates of incorporation of intravenously injected radiolabeled fatty acids into phospholipids of intracerebrally implanted tumor and brain in awake rats.

Authors:  T Nariai; J J DeGeorge; N H Greig; S Genka; S I Rapoport; A D Purdon
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

3.  Eicosanoid production by brain tumours in vivo--evidence for intracranial compartmentation.

Authors:  V Walker; J D Pickard; P J Smythe; S Perry
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

4.  Adrenergic and cholinergic stimulation of arachidonate and phosphatidate metabolism in cultured astroglial cells.

Authors:  J J DeGeorge; P Morell; K D McCarthy; E G Lapetina
Journal:  Neurochem Res       Date:  1986-07       Impact factor: 3.996

5.  Gene dosage of CuZnSOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice.

Authors:  D Minc-Golomb; H Knobler; Y Groner
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

Review 6.  Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2008-10-15       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.